CoQ10 (ubiquinol)

CoQ10 (coenzyme Q10, also called ubiquinone in its oxidised form and ubiquinol in its reduced form) is a fat-soluble molecule your mitochondria use to make ATP. Every cell in your body needs it, but the heart, kidneys, liver, and skeletal muscle, the tissues with the highest energy demand, depend on it the most. Your body makes its own and you get a small amount from meat and fish, but production drops noticeably from your 40s onward, and certain medications (statins in particular) suppress it further.

Most people end up taking it because they're on a statin and want to offset the drop in CoQ10 that comes with it, they're managing heart failure or hypertension as adjunctive support, or they're trying to slow age-related mitochondrial decline. There's also a real signal for migraine prevention and for women trying to conceive in their late 30s and 40s, where CoQ10 may improve egg quality. The benefit is mostly preventive and slow-acting, not something you feel day to day, which is why many people stop taking it before it has a chance to do anything.

Deep-dive

CoQ10 sits inside the inner mitochondrial membrane and shuttles electrons between Complex I/II and Complex III in the electron transport chain. Without enough CoQ10, that chain runs less efficiently, ATP output falls, and electron leak generates more reactive oxygen species. The molecule cycles between two forms: ubiquinone (oxidised) accepts electrons, and ubiquinol (reduced) donates them. The reduced form also acts as a potent lipid-soluble antioxidant, protecting cell membranes and LDL particles from oxidation, and it regenerates vitamin E and vitamin C back to their active forms.

Endogenous CoQ10 synthesis happens in nearly every cell via the mevalonate pathway, the same pathway that produces cholesterol. This is why statins lower CoQ10. They block HMG-CoA reductase at the top of the pathway to reduce cholesterol output, but they also reduce mevalonate, which is a precursor for CoQ10. The result is a 20-40% reduction in plasma CoQ10 on standard statin doses, with the magnitude scaling with the statin dose. Whether this depletion drives statin-related muscle symptoms is still debated, but the biochemistry is clear.

Heart failure. This is the strongest hard-endpoint evidence. The Q-SYMBIO trial, a multicentre RCT of 420 patients with moderate to severe chronic heart failure, randomised participants to 100 mg of CoQ10 three times daily or placebo on top of standard therapy. Over 2 years, the CoQ10 group had a 43% reduction in major adverse cardiovascular events, a 42% reduction in all-cause mortality, and improved NYHA functional class. The European subgroup analysis confirmed the effect with a measurable improvement in left ventricular ejection fraction. This is one of the few supplements with a randomised mortality signal in cardiovascular disease, and it sits on top of, not in place of, standard heart failure therapy.

Older adults and longevity. The KiSel-10 trial gave 443 healthy elderly Swedes 200 mg CoQ10 plus 200 µg selenium daily for 4 years. After 10 years of follow-up, the active group had a roughly 49% reduction in cardiovascular mortality (HR 0.51), and the effect persisted at the 12-year mark. The sex-stratified analysis showed comparable benefit in both men and women. The combination matters here, selenium is a cofactor for the enzymes that keep CoQ10 in its active reduced form, and Sweden has low dietary selenium, so the effect may not generalise everywhere. But it's the cleanest long-term mortality data CoQ10 has.

Statin myopathy. The evidence is genuinely mixed. A 2018 meta-analysis of 12 RCTs (575 patients) found CoQ10 supplementation significantly improved statin-associated muscle pain, weakness, cramps, and tiredness, but did not lower creatine kinase. A more recent 2024 systematic review of 5 RCTs (800 patients) reported all included trials showed improvement. Against this, a well-designed crossover trial of 41 patients with confirmed statin myalgia, where a placebo lead-in eliminated nocebo responders, found 600 mg/day ubiquinol did nothing for muscle pain. The honest read: if statin muscle symptoms are bothering you and you've ruled out the placebo effect, CoQ10 is cheap and safe to try, but don't expect it to work for everyone.

Blood pressure. A 2025 meta-analysis of 45 RCTs in 2,932 adults found CoQ10 reduced systolic blood pressure by about 3.4 mmHg with no significant effect on diastolic. A dose-response analysis in cardiometabolic patients found a clinically optimal dose of 100-200 mg/day for BP lowering. The effect is modest, similar to a low-dose pharmaceutical, and it's an add-on, not a replacement.

Migraine. Multiple adult RCTs support a benefit. The original 2005 trial randomised 42 migraineurs to 300 mg/day or placebo. By month three, the responder rate (≥50% reduction in attack frequency) was 47.6% on CoQ10 versus 14.4% on placebo, with a number-needed-to-treat of 3. A women-only trial of 84 episodic migraineurs and an open-label add-on trial of 80 adults both showed reductions in attack frequency and severity. A paediatric crossover trial, however, found CoQ10 no better than placebo in children and adolescents, both groups improved equally with multidisciplinary care. So adult evidence is solid, paediatric evidence is not.

Female fertility and egg quality. Mitochondrial dysfunction in oocytes is one of the main drivers of declining egg quality with age. A 2018 RCT in 169 young women with poor ovarian reserve gave 60 days of CoQ10 pretreatment before IVF and found significantly more retrieved oocytes, higher fertilisation rates, more high-quality embryos, and fewer cancelled embryo transfers (8.3% vs 22.9%). Clinical pregnancy and live birth rates trended higher but didn't reach statistical significance. A 2024 meta-analysis of 20 RCTs (2,617 women) on antioxidants and ovarian aging found CoQ10 increased oocyte yield, embryo quality, and clinical pregnancy rates. If you're a woman over 35 trying to conceive, especially with diminished ovarian reserve, this is one of the better-supported uses.

Form: ubiquinol vs ubiquinone. Marketing pushes ubiquinol hard as the superior form. The reality is more boring. A head-to-head bioavailability study in healthy elderly found ubiquinol was 1.7x better absorbed than standard ubiquinone capsules but the difference wasn't statistically significant, and a properly formulated water-soluble ubiquinone outperformed both. Critically, CoQ10 appears in the bloodstream almost exclusively as ubiquinol regardless of which form you take, because it's reduced during absorption. The clinical evidence for hard endpoints (Q-SYMBIO for heart failure, KiSel-10 for mortality, the migraine trials) was built on ubiquinone. Ubiquinol is genuinely worth the premium if you're over 60, have impaired absorption, or aren't responding to ubiquinone, otherwise a quality ubiquinone softgel taken with fat does the job.

Women. Most CoQ10 trials have included both sexes and effects are broadly comparable. The KiSel-10 sex analysis found similar cardiovascular mortality reduction in men and women. The fertility evidence is obviously female-specific and represents the strongest case for younger and middle-aged women to consider supplementation. Women on hormonal contraceptives may have slightly lower baseline CoQ10 levels, as do women with hypothyroidism. Pregnancy and breastfeeding data is limited, the IVF studies are pre-conception only, so don't continue once pregnant unless your doctor specifically recommends it.

Dosage:

Standard dose: 100-200 mg/day with a meal containing fat. This covers most general use cases including statin offset, blood pressure support, and longevity dosing

Heart failure (adjunctive, with cardiologist oversight): 300 mg/day split into 2-3 doses, the Q-SYMBIO protocol

Migraine prevention: 100 mg three times daily (300 mg total). Allow 8-12 weeks to assess response, the effect builds slowly

Statin offset: 100-200 mg/day. If you're on a high-dose statin (atorvastatin 40-80 mg, rosuvastatin 20-40 mg), 200 mg is more appropriate

Female fertility (poor responder protocol): 200-600 mg/day for 60+ days before IVF cycle, ideally under reproductive endocrinologist supervision

Form: A quality ubiquinone softgel works for most people under 60. Switch to ubiquinol if you're over 60, on a high dose for cardiac indications, or not seeing the expected response. Plain capsules of crystalline CoQ10 powder absorb poorly, look for softgels or oil-suspended formulations

Timing: Take with the largest fat-containing meal of the day. CoQ10 is highly lipophilic and absorption can be 3-4x higher with dietary fat. Splitting doses above 200 mg into 2-3 administrations meaningfully improves absorption

Onset: Plasma levels peak around 6-8 hours after a single dose and reach steady state in 2-3 weeks. Clinical effects take longer, 4-12 weeks for migraine, 3-6 months for blood pressure and cardiac endpoints

Stacks: Pairs naturally with selenium (the KiSel-10 combination), particularly if you live in a low-selenium region. Often co-prescribed with omega-3s in heart failure protocols. Tocotrienols may help preserve ubiquinol from oxidation. Avoid combining with other antioxidants in the immediate post-workout window if your goal is hypertrophy

Here's what you can expect:

For most uses, CoQ10 is a slow, quiet supplement. You won't feel anything from the first dose, or the first week. The clinical effects are real but they show up in measurements and outcomes, not subjective experience.

If you're taking it for migraine prevention, expect 8-12 weeks before judging whether it's working. The benefit is fewer attacks per month, not aborting an attack in progress.

If you're taking it on a statin to offset CoQ10 depletion or to address muscle symptoms, give it 4-8 weeks. Some people notice less muscle achiness, others notice nothing. The biochemical replenishment happens regardless of whether you feel it.

If you're taking it for blood pressure, the drop is modest (around 3-4 mmHg systolic) and shows up over 8-12 weeks. Don't expect it to replace medication, but it can stack with lifestyle changes and other interventions.

If you're taking it for heart failure under cardiology supervision, the timeline for symptom improvement is 3-6 months and the mortality benefit accrues over years.

If you're a woman taking it for egg quality before IVF, the relevant window is 60-90 days of pretreatment, which matches the timeline for follicular development.

The most common reason people abandon CoQ10 is impatience. The second most common is taking it without dietary fat and not absorbing enough to matter.

Side effects & risks:

Generally extremely well tolerated. A safety trial of 300, 600, and 900 mg/day showed no dose-dependent adverse effects over 4 weeks. Long-term use at 100-300 mg/day across multiple multi-year trials has been uneventful

GI side effects are the most common, mild nausea, loss of appetite, abdominal discomfort, or loose stools. Usually resolves by splitting the dose or taking with more food

Insomnia in a small subset of users if taken in the evening. The mechanism isn't clear but it does happen. Take it with breakfast or lunch if you're sensitive

Headache and dizziness occasionally, usually transient

Mild rash or itching in rare cases

Warfarin interaction is the one to actually pay attention to. CoQ10 is structurally similar to vitamin K and may reduce the anticoagulant effect of warfarin, increasing clot risk. The data is mixed but the signal exists. If you're on warfarin, don't start or stop CoQ10 without telling your prescriber and getting more frequent INR checks. The newer DOACs (apixaban, rivaroxaban) have no documented interaction

Blood pressure medications: CoQ10 can lower BP modestly, so the additive effect with antihypertensives can occasionally cause hypotension or lightheadedness. If you're on multiple BP medications, check your readings when starting

Diabetes medications: small possibility of additive glucose-lowering effect with insulin or sulfonylureas. Worth monitoring fingersticks for the first couple of weeks

Chemotherapy: theoretical concern that the antioxidant activity of CoQ10 could blunt the effect of chemotherapies and radiation that work through oxidative damage. The evidence is thin but for active oncology patients this is a discussion to have with your oncologist before starting

Pregnancy: limited data. Pre-IVF use has a reasonable evidence base but ongoing use during pregnancy isn't well studied, hold unless your obstetrician specifically recommends it

No significant toxicity ceiling has been identified. Doses up to 1,200 mg/day for 16 months have been used in Parkinson's trials without serious adverse events. This is a genuinely low-risk supplement for the general population

🩸

Blood markers

Plasma/serum CoQ10, baseline if you have a specific reason to test it (statin therapy, heart failure, suspected mitochondrial issues, or you want to confirm absorption). The adult reference range is roughly 0.5-1.7 µmol/L (or about 0.4-1.9 µg/mL depending on the lab). Recheck at 2-3 months on supplementation to confirm you've moved into the upper end of the range. Therapeutic targets in heart failure literature are often >2.5 µg/mL.

Lipid panel (total cholesterol, LDL, HDL, triglycerides), baseline and at 3 months if you're using CoQ10 alongside a statin, useful both for tracking the statin's primary effect and because CoQ10 in plasma correlates with lipid levels.

INR, baseline and more frequently for the first month if you're on warfarin and starting CoQ10. Don't skip this, the interaction is the one real safety issue.

Blood pressure, baseline and at 8-12 weeks if you're using CoQ10 for hypertension or stacking it with antihypertensives. The drop is modest but worth tracking.

For the average person taking 100-200 mg/day for general longevity or to offset age-related decline, no specific bloodwork is required. The people who actually need monitoring are those on warfarin, those on a statin, those using high doses for a cardiac indication, and women using it as IVF pretreatment under reproductive endocrinology care.

Sold as a dietary supplement in most countries without prescription.